Items where authors include "Moore, SC"

Article

Liew, F, Talwar, S, Cross, A et al. (40 more authors) (2023) SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination. EBioMedicine, 87. 104402. ISSN 2352-3964

Relph, KA, Russell, CD, Fairfield, CJ et al. (365 more authors) (2022) Procalcitonin is not a reliable biomarker of bacterial coinfection in people with coronavirus disease 2019 undergoing microbiological investigation at the time of hospital admission. Open Forum Infectious Diseases, 9 (5). ofac179.

Tomic, A, Skelly, DT, Ogbe, A et al. (105 more authors) (2022) Divergent trajectories of antiviral memory after SARS-CoV-2 infection. Nature Communications, 13 (1). 1251. ISSN 2041-1723

Dejnirattisai, W, Huo, J, Zhou, D et al. (461 more authors) (2022) SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell, 185 (3). 467-484.e15. ISSN 0092-8674

Sullivan, MK, Lees, JS, Drake, TM et al. (362 more authors) (2022) Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study : a prospective, multicentre cohort study. Nephrology Dialysis Transplantation, 37 (2). pp. 271-284. ISSN 0931-0509

Angyal, A, Longet, S, Moore, SC et al. (176 more authors) (2022) T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study. The Lancet Microbe, 3 (1). e21-e31. ISSN 2666-5247

Niemi, MEK, Karjalainen, J, Liao, RG et al. (3763 more authors) (2021) Mapping the human genetic architecture of COVID-19. Nature, 600 (7889). pp. 472-477. ISSN 0028-0836

de Silva, TI orcid.org/0000-0002-6498-9212, Liu, G, Lindsey, BB orcid.org/0000-0003-4227-2592 et al. (1010 more authors) (2021) The impact of viral mutations on recognition by SARS-CoV-2 specific T cells. iScience, 24 (11). 103353. ISSN 2589-0042

Payne, RP, Longet, S, Austin, JA et al. (132 more authors) (2021) Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine. Cell, 184 (23). 5699-5714.e11. ISSN 0092-8674

Wickenhagen, A, Sugrue, E, Lytras, S et al. (420 more authors) (2021) A prenylated dsRNA sensor protects against severe COVID-19. Science, 374 (6567). eabj3624. ISSN 0036-8075

Skelly, DT, Harding, AC, Gilbert-Jaramillo, J et al. (92 more authors) (2021) Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern. Nature Communications, 12 (1). 5061.

Russell, CD, Fairfield, CJ, Drake, TM et al. (369 more authors) (2021) Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study : a multicentre, prospective cohort study. The Lancet Microbe, 2 (8). e354-e365.

Drake, TM, Riad, AM, Fairfield, CJ et al. (400 more authors) (2021) Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. The Lancet, 398 (10296). pp. 223-237. ISSN 0140-6736

Docherty, AB, Mulholland, RH, Lone, NI et al. (377 more authors) (2021) Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. The Lancet Respiratory Medicine, 9 (7). pp. 773-785. ISSN 2213-2600

Drake, TM, Fairfield, CJ, Pius, R et al. (359 more authors) (2021) Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. The Lancet Rheumatology, 3 (7). e498-e506. ISSN 2665-9913

Bloom, CI, Drake, TM, Docherty, AB et al. (340 more authors) (2021) Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19 : a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. The Lancet Respiratory Medicine, 9 (7). pp. 699-711. ISSN 2213-2600

Leclerc, QJ, Fuller, NM, Keogh, RH et al. (384 more authors) (2021) Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England. BMC Health Services Research, 21. 566. ISSN 1472-6963

Ogbe, A, Kronsteiner, B, Skelly, DT et al. (77 more authors) (2021) T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. Nature Communications, 12 (1). 2055.

Gupta, RK, Harrison, EM, Ho, A et al. (372 more authors) (2021) Development and validation of the ISARIC 4C deterioration model for adults hospitalised with COVID-19: a prospective cohort study. The Lancet Respiratory Medicine, 9 (4). pp. 349-359. ISSN 2213-2600

Pairo-Castineira, E, Clohisey, S, Klaric, L et al. (63 more authors) (2021) Genetic mechanisms of critical illness in Covid-19. Nature, 591 (7848). pp. 92-98. ISSN 0028-0836

Drake, TM, Docherty, AB, Harrison, EM et al. (398 more authors) (2020) Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study. American Journal of Respiratory and Critical Care Medicine, 202 (12). pp. 1656-1665. ISSN 1073-449X

Peng, Y, Mentzer, AJ, Liu, G et al. (61 more authors) (2020) Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nature Immunology, 21 (11). pp. 1336-1345. ISSN 1529-2908